Emerging pathogens and their implications for the blood supply and transfusion transmitted infections

The threat of infection by conventional transfusion‐transmitted agents has been essentially eliminated from the blood supply in developed countries, thus focusing attention on the potential risk from emerging infections. Over recent years, actions have been taken to manage a number of such risks to blood safety. These illustrate the inherent variability of the agents concerned and of the measures needed to define and control the risk.

• Publication year

  2012

• Venue

  British Journal of Haematology

• Publication date

  2012-08-28

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.1111/bjh.12031PMID 22924410PMCID 7161751
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Xenotropic murine leukemia virus–related virus does not pose a risk to blood recipient safety

  2012cited by this paper
• Review: Creutzfeldt–Jakob disease: prion protein type, disease phenotype and agent strain

  2012influential reference
• Human babesiosis.

  2012cited by this paper
• Trypanosoma cruzi infection in North America and Spain: evidence in support of transfusion transmission (CME)

  2012cited by this paper
• Coxiella burnetii infection among blood donors during the 2009 Q‐fever outbreak in the Netherlands

  2012cited by this paper
• The United States Trypanosoma cruzi Infection Study: evidence for vector‐borne transmission of the parasite that causes Chagas disease among United States blood donors

  2012influential reference
• Dengue viremia in blood donors identified by RNA and detection of dengue transfusion transmission during the 2007 dengue outbreak in Puerto Rico

  2012cited by this paper
• Preventing transfusion‐transmitted babesiosis: preliminary experience of the first laboratory‐based blood donor screening program

  2012cited by this paper
• Transfusion-Transmitted Babesia spp.: Bull's-Eye on Babesia microti

  2011cited by this paper
• Recombinant Origin of the Retrovirus XMRV

  2011cited by this paper
• West Nile virus infection transmitted by granulocyte transfusion.

  2011cited by this paper
• Recombinant Origin of the Retrovirus XMRV

  2011cited by this paper
• Failure to Confirm XMRV/MLVs in the Blood of Patients with Chronic Fatigue Syndrome: A Multi-Laboratory Study

  2011cited by this paper
• Retraction for Lo et al., Detection of MLV-related virus gene sequences in blood of patients with chronic fatigue syndrome and healthy blood donors

  2011cited by this paper
• Cultivating a demand for clean cookstoves.

  2011cited by this paper
• Transfusion-Associated Babesiosis in the United States: A Description of Cases

  2011cited by this paper
• Comment on “Detection of an Infectious Retrovirus, XMRV, in Blood Cells of Patients with Chronic Fatigue Syndrome”

  2010cited by this paper
• Detection of MLV-related virus gene sequences in blood of patients with chronic fatigue syndrome and healthy blood donors

  2010cited by this paper
• Q fever in the Netherlands: an update on the epidemiology and control measures.

  2010cited by this paper
• Microbe Hunting

  2010cited by this paper
• Transfusion transmission of highly prevalent commensal human viruses

  2010cited by this paper
• Detection of an Infectious Retrovirus, XMRV, in Blood Cells of Patients with Chronic Fatigue Syndrome

  2009cited by this paper
• Transfusion of platelet components prepared with photochemical pathogen inactivation treatment during a Chikungunya virus epidemic in Ile de La Réunion

  2009cited by this paper
• Emerging infectious disease agents and their potential threat to transfusion safety

  2009influential reference
• Human RNA “Rumor” Viruses: the Search for Novel Human Retroviruses in Chronic Disease

  2008cited by this paper
• Emerging infections: a perpetual challenge

  2008cited by this paper
• Estimated risk of Chikungunya viremic blood donation during an epidemic on Reunion Island in the Indian Ocean, 2005 to 2007

  2008cited by this paper
• A nationwide survey for hepatitis E virus prevalence in Japanese blood donors with elevated alanine aminotransferase

  2008cited by this paper
• Review of dengue fever cases in Hong Kong during 1998 to 2005.

  2008cited by this paper
• The Chikungunya epidemic in Italy and its repercussion on the blood system.

  2008cited by this paper
• A new arenavirus in a cluster of fatal transplant-associated diseases.

  2008cited by this paper
• Dengue Hemorrhagic Fever Transmitted by Blood Transfusion

  2008cited by this paper
• Dengue hemorrhagic fever transmitted by blood transfusion.

  2008cited by this paper
• A Single Mutation in Chikungunya Virus Affects Vector Specificity and Epidemic Potential

  2007cited by this paper
• Chikungunya outbreaks--the globalization of vectorborne diseases.

  2007cited by this paper
• Modern Plasma Fractionation

  2007cited by this paper
• West Nile Virus Among Blood Donors in the United States, 2003 and 2004

  2007cited by this paper
• Creutzfeldt–Jakob disease and blood transfusion: results of the UK Transfusion Medicine Epidemiological Review study

  2006cited by this paper
• Identification of a Novel Gammaretrovirus in Prostate Tumors of Patients Homozygous for R462Q RNASEL Variant

  2006cited by this paper
• Transfusion‐transmitted hepatitis E in a ‘nonhyperendemic’ country

  2006cited by this paper
• Reduction of transmissible spongiform encephalopathy infectivity from human red blood cells with prion protein affinity ligands

  2006influential reference
• Clearance of prions during plasma protein manufacture.

  2006cited by this paper
• Natural history and pathophysiology of Q fever.

  2005cited by this paper
• Systematic review and meta-analysis of strategies for the diagnosis of suspected pulmonary embolism

  2005influential reference
• Parvovirus B19 Infection

  2004cited by this paper
• Social and environmental risk factors in the emergence of infectious diseases

  2004influential reference
• Westward ho?--The spread of West Nile virus.

  2004influential reference
• Severe acute respiratory syndrome

  2004cited by this paper
• Parvovirus B19.

  2004cited by this paper
• Title The Severe Acute Respiratory Syndrome

  2003cited by this paper
• Transmission of West Nile virus through blood transfusion in the United States in 2002.

  2003influential reference
• The Severe Acute Respiratory Syndrome

  2003influential reference
• First hundred cases of variant Creutzfeldt-Jakob disease: retrospective case note review of early psychiatric and neurological features

  2002cited by this paper
• Estimated risk of West Nile virus transmission through blood transfusion during an epidemic in Queens, New York City

  2002cited by this paper
• Human babesiosis in New York State: Review of 139 hospitalized cases and analysis of prognostic factors.

  1998cited by this paper
• [Parvovirus B19].

  1995cited by this paper
• Creutzfeldt-Jakob disease and blood transfusion.

  1991cited by this paper
• Supporting Online Material Recombinant Origin of the Retrovirus Xmrv

  year unknowncited by this paper

• The American Rare Donor Program: 25 years supporting rare blood needs

  2024cites this paper
• Therapeutic Targets in the Virological Mechanism and in the Hyperinflammatory Response of Severe Acute Respiratory Syndrome Coronavirus Type 2 (SARS-CoV-2)

  2023cites this paper
• ZIF-8 metal organic framework nanoparticle loaded with tense quaternary state polymerized bovine hemoglobin: potential red blood cell substitute with antioxidant properties.

  2023cites this paper
• Assessing quality of blood components derived from whole blood treated with riboflavin and ultraviolet light and separated with a fully automated device.

  2022cites this paper
• Evidence of pediatric sepsis caused by a drug resistant Lactococcus garvieae contaminated platelet concentrate

  2022cites this paper
• The EHA Research Roadmap: Transfusion Medicine

  2022cites this paper
• Cellular Therapy as Promising Choice of Treatment for COVID-19

  2021cites this paper
• Antiviral treatment in COVID-19: which is the most promising?-a narrative review.

  2021cites this paper
• An overview of some potential immunotherapeutic options against COVID-19

  2021cites this paper
• The Most Common Causes of Transfusion-Transmitted Diseases among Blood Donors in the Middle Eastern States

  2021cites this paper
• Convalescent plasma therapy and COVID-19

  2020cites this paper
• Potential Therapeutic Options for COVID-19: Current Status, Challenges, and Future Perspectives

  2020cites this paper
• Medical Management of COVID-19: Evidence and Experience

  2020cites this paper
• Current status of potential therapeutic candidates for the COVID-19 crisis

  2020influential citation
• Plasma convalescente como alternativa ao tratamento aplicado à Covid-19

  2020cites this paper
• [Transfusion of convalescent plasma from patients with COVID -19].

  2020cites this paper
• Convalescent Plasma Therapy and its Century-Old Untapped Potential for COVID-19

  2020cites this paper
• COVID-19 Pandemic: Evidences from Clinical Studies

  2020cites this paper
• Metagenomic analysis and identification of emerging pathogens in blood from healthy donors

  2020cites this paper
• Clinical Utility of Autologous Salvaged Blood: a Review

  2019cites this paper
• Refrigeration, cryopreservation and pathogen inactivation: an updated perspective on platelet storage conditions

  2018cites this paper
• Emerging infectious disease outbreaks: estimating disease risk in Australian blood donors travelling overseas

  2018cites this paper
• Reflections on Dry Eye Syndrome Treatment: Therapeutic Role of Blood Products

  2018cites this paper
• Frequency of bacterial contamination in platelet concentrates in a tertiary care cardiac hospital in Rawalpindi, Pakistan.

  2018cites this paper
• Influence of platelet preparation techniques on in vitro storage quality after psoralen‐based photochemical treatment using new processing sets for triple‐dose units

  2018cites this paper
• Emerging infectious diseases and blood donation

  2018cites this paper
• Decision making in the face of uncertainty: the challenge of emerging infectious diseases

  2017cites this paper
• TRUISM (TRANSFUSION INVENTORY PROCESS MINING FRAMEWORK): A PROCESS MINING-BASED FRAMEWORK FOR UNDERSTANDING BLOOD TRANSFUSION PRODUCT INVENTORIES

  2017cites this paper
• Prioritizing of bacterial infections transmitted through substances of human origin in Europe

  2017cites this paper
• Second Place Award: Tranexamic acid and intrathecal morphine are synergistic in reducing transfusion requirements in pediatric posterior spinal fusion

  2017cites this paper
• Implementing a Health System–wide Patient Blood Management Program with a Clinical Community Approach

  2017cites this paper
• Preparation of Platelet Concentrates for Research and Transfusion Purposes.

  2017cites this paper
• Transfusion-related immunomodulation: a reappraisal

  2017cites this paper
• Towards pathogen inactivation of red blood cells and whole blood targeting viral DNA/RNA: design, technologies, and future prospects for developing countries.

  2017cites this paper
• Predictors of Intraoperative Blood Transfusion in Free Tissue Transfer

  2016cites this paper
• A consensus‐based tool for ranking the risk of blood‐transmissible infections

  2016cites this paper
• Solvent/Detergent Virally Inactivated Serum Eye Drops Restore Healthy Ocular Epithelium in a Rabbit Model of Dry-Eye Syndrome

  2016cites this paper
• Functional characteristics and clinical effectiveness of platelet concentrates treated with riboflavin and ultraviolet light in plasma and in platelet additive solution

  2016cites this paper
• Reevaluating Canada’s policy for blood donations from men who have sex with men (MSM)

  2016cites this paper
• Improving platelet transfusion safety: biomedical and technical considerations.

  2016cites this paper
• Blood-Borne Pathogens: A Canadian Blood Services Centre for Innovation Symposium

  2016cites this paper
• Convalescent plasma: new evidence for an old therapeutic tool?

  2016cites this paper
• Preventing bacterial infection in blood components

  2016cites this paper
• Część I: Wytyczne postępowania w hemofilii A i B niepowikłanej inhibitorem czynnika VIII i IX (wydanie zaktualizowane)

  2016cites this paper
• Evaluating the risks posed by hepatitis E virus to blood supply safety

  2016influential citation
• Toward a Sustainable Blood Supply in the United States

  2016cites this paper
• Reevaluating Canada’s policy for blood donations from men who have sex with men (MSM)

  2016cites this paper
• Hepatitis E virus infection: Epidemiology and treatment implications.

  2015cites this paper
• Evaluation of the effectiveness of a pathogen inactivation technology against clinically relevant transfusion‐transmitted bacterial strains

  2015cites this paper
• Hematologic problems in the Critically III

  2015cites this paper
• Technical challenges in human islet isolation

  2015cites this paper
• Seroprevalence of Antibodies to Ross River and Barmah Forest Viruses: Possible Implications for Blood Transfusion Safety After Extreme Weather Events

  2015cites this paper
• The effect of riboflavin and ultraviolet light on the infectivity of arboviruses

  2015cites this paper
• Bitten by a bug or a bag? Transfusion‐transmitted dengue: a rare complication in the bleeding surgical patient

  2015cites this paper
• Pathogen Inactivation Technologies for Cellular Blood Components: an Update

  2014cites this paper
• Red blood cell transfusions for thalassemia: results of a survey assessing current practice and proposal of evidence‐based guidelines

  2014cites this paper
• Ebola virus convalescent blood products: Where we are now and where we may need to go

  2014cites this paper
• Oxygen removal during pathogen inactivation with riboflavin and UV light preserves protein function in plasma for transfusion

  2014cites this paper
• “Go no Go” in plasma fractionation in the world's emerging economies: Still a question asked 70 years after the COHN process was developed!

  2014cites this paper
• Preparation, quality criteria, and properties of human blood platelet lysate supplements for ex vivo stem cell expansion

  2014cites this paper
• need to go

  2014cites this paper
• Infektionsprävention im Blutspendewesen

  2014cites this paper
• Pathogen-free, plasma-poor platelet lysate and expansion of human mesenchymal stem cells

  2014cites this paper
• Pathogen reduction technologies

  2014cites this paper
• Adverse Transfusion Reactions in Critically Ill Patients

  2014cites this paper
• Rôle inflammatoire des plaquettes sanguines : application en transfusion

  2013cites this paper
• High-throughput Gene Expression Profiling: Its Application in Studying Transfusion-Transmitted Infections

  2013cites this paper
• CHILDREN WITH LIVER DISEASE

  2013cites this paper
• Coagulation in children with liver disease

  2013cites this paper
• Platelet concentrates for transfusion: Preparation, principle and safety criteria for optimal tolerance and reduction of hazards

  2013cites this paper
• AN EDUCATIONAL RESOURCE PUBLISHED BY AMERICAN RED CROSS BLOOD SERVICES | WINTER 2016

  2012cites this paper